High Tumor Volume to Fetal Weight Ratio Is Associated with Worse Fetal Outcomes and Increased Maternal Risk in Fetuses with Sacrococcygeal Teratoma

Conclusion: This study supports the use of TFR at ≤24 weeks for risk stratification of pregnancies with SCT.Fetal Diagn Ther

Source: Fetal Diagnosis and Therapy - March 1, 2018 Category: Perinatology & Neonatology Source Type: research